-
February 7, 2025
Safety
New
PMDA Risk Communication: Axicabtagene ciloleucel, etc. posted
-
February 7, 2025
Safety
New
PMDA Risk Communication: Desmopressin acetate hydrate, etc. posted
-
February 5, 2025
Safety
New
PMDA Medical Safety Information: Cases of Air Embolism Due to the Use of Central Venous Catheters (No. 71) posted
-
January 29, 2025
Safety
Revisions of PRECAUTIONS: Ethical combination drugs (Brand name: Twinpal Injection), etc. posted
-
January 22, 2025
Safety
MHLW Pharmaceuticals and Medical Devices Safety Information No.416 posted
-
January 6, 2025
Safety
Notification Related to Safety Measures (Regenerative Medical Products) : Instructions for Electronic Package Inserts of Regenerative Medical Products posted
-
December 17, 2024
Safety
PMDA Alert for Proper Use of Drugs: Administration of Treatment Drugs for COVID-19 (Xocova Tablets and Lagevrio Capsules) to Women of Childbearing Potential posted
-
December 17, 2024
Safety
Notification Related to Safety Measures (Regenerative Medical Products) : Instructions for Electronic Package Inserts of Regenerative Medical Products posted
-
October 24, 2024
Safety
Update: Publication of MIHARI project
-
June 20, 2024
Safety
Notifications Related to Safety Measures (Drugs): ”Amendment of the Instructions for Electronic Package Inserts Regarding Results of Studies Using Medical Information Database” and “Points to Consider for Describing the Results of Studies Using Medical Information Database in Electronic Package Inserts” posted
-
April 10, 2024
Safety
Notifications Related to Safety Measures (medical devices): Questions and Answers (Q&A) on MR Safety of Implantable Medical Devices, etc. (Part 2) posted
-
March 28, 2024
Safety
Revisions of PRECAUTIONS (Regenerative Medical Products): Axicabtagene ciloleucel, etc. posted
-
March 28, 2024
Safety
Revisions of PRECAUTIONS: Andexanet alfa (genetical recombination) posted
-
March 14, 2024
Safety
MHLW Pharmaceuticals and Medical Devices Safety Information No.408
-
February 29, 2024
Safety
Notifications Related to Safety Measures (in vitro diagnostics) : Points to Consider, etc. for Consultation Associated With Revision, etc. of Package Inserts, etc. posted
-
December 27, 2023
Safety
English Translated Package Inserts page: Ensure Liquid updated
-
March 27, 2023
Safety
Revisions of PRECAUTIONS:Anti-human thymocyte immunoglobulin, rabbit posted
-
March 14, 2023
Safety
MHLW Pharmaceuticals and Medical Devices Safety Information No.399
-
July 29, 2022
Safety
Risk Management Plan (RMP) :RMP Page renewal, Questions and Answers (Qs and As) on Risk Management Plan, Risk Management Plan templates, instructions and publication posted
-
March 23, 2022
Safety
Revisions of PRECAUTIONS: Ticagrelor, etc. posted
-
March 11, 2022
Safety
PMDA Alert for Proper Use of Medical Devices: Bleeding Caused by the Use of IMPELLA Circulatory Assistance Pump Catheter, posted
-
March 8, 2022
Safety
MHLW Pharmaceuticals and Medical Devices Safety Information No.390
-
December 24, 2021
Safety
Revisions of PRECAUTIONS (Medical Devices): Power Morcellators posted
-
June 1, 2021
Safety
Urgent Safety Information (the blue letter) Joyclu, has been posted.
-
March 30, 2021
Safety
Revisions of PRECAUTIONS (Cellular and Tissue-based Products): Onasemnogene abeparvovec, posted
-
March 30, 2021
Safety
Revisions of PRECAUTIONS: Magnesium sulfate hydrate/glucose, etc. posted
-
March 23, 2021
Safety
MHLW Pharmaceuticals and Medical Devices Safety Information No.381
-
February 18, 2021
Safety
Notification on self-check, posted
-
February 18, 2021
Safety
PMDA Risk Communication (Medical devices Risk Information of ongoing evaluation) :Drug-eluting coronary stent, etc. posted
-
July 10, 2020
Safety
PMDA Alert for Proper Use of Medical Devices (for patients): For patients who use a ventilator, etc. at home and their families or other caregivers, posted
-
March 31, 2020
Safety
Revisions of PRECAUTIONS:Spiperone, etc. posted
-
March 24, 2020
Safety
MHLW Pharmaceuticals and Medical Devices Safety Information No.371
-
March 28, 2019
Safety
Revisions of PRECAUTIONS:Amobarbital, etc. posted
-
March 12, 2019
Safety
MHLW Pharmaceuticals and Medical Devices Safety Information No.361
-
March 27, 2018
Safety
Revisions of PRECAUTIONS: Adrenaline, etc. posted
-
March 14, 2018
Safety
MHLW Pharmaceuticals and Medical Devices Safety Information No.351
-
March 21, 2017
Safety
Revisions of PRECAUTIONS: Lamotrigine, etc. posted
-
April 18, 2016
Safety
Investigation results: Mycophenolate Mofetil posted
-
March 24, 2016
Safety
MHLW Pharmaceuticals and Medical Devices Safety Information No.331
-
June 30, 2015
Safety
Notification on Self-inspection: Electric massage devices for home use
-
May 19, 2015
Safety
MHLW Pharmaceuticals and Medical Devices Safety Information No.321
-
April 8, 2015
Safety
Revisions of PRECAUTIONS (Summary of investigation results): cetuximab and panitumumab posted